These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Lessons Learned From the Clinical Trials of Novel Biologics and Small Molecules in Lupus Nephritis. Furie R; Toder K; Zapantis E Semin Nephrol; 2015 Sep; 35(5):509-20. PubMed ID: 26573553 [TBL] [Abstract][Full Text] [Related]
6. New and future therapies for lupus nephritis. Appel GB Cleve Clin J Med; 2012 Feb; 79(2):134-40. PubMed ID: 22301564 [TBL] [Abstract][Full Text] [Related]
7. Lupus nephritis: keeping the wolf at bay. Radhakrishnan J Clin J Am Soc Nephrol; 2013 Jan; 8(1):136-7. PubMed ID: 23296379 [No Abstract] [Full Text] [Related]
8. Mycophenolate mofetil for lupus nephritis: an update. Mok CC Expert Rev Clin Immunol; 2015; 11(12):1353-64. PubMed ID: 26364748 [TBL] [Abstract][Full Text] [Related]
9. Treatment of proliferative lupus nephritis: a changing landscape. Adu D Kidney Int; 2006 Aug; 70(4):616-8. PubMed ID: 16900218 [TBL] [Abstract][Full Text] [Related]
10. A decade of mycophenolate mofetil for lupus nephritis: is the glass half-empty or half-full? Boumpas DT; Bertsias GK; Balow JE Ann Rheum Dis; 2010 Dec; 69(12):2059-61. PubMed ID: 21097656 [No Abstract] [Full Text] [Related]
11. Treatment of severe lupus nephritis: the new horizon. Chan TM Nat Rev Nephrol; 2015 Jan; 11(1):46-61. PubMed ID: 25421826 [TBL] [Abstract][Full Text] [Related]
12. The evidence base for the treatment of lupus nephritis in the new millennium. Adu D Nephrol Dial Transplant; 2001 Aug; 16(8):1536-8. PubMed ID: 11477149 [No Abstract] [Full Text] [Related]
13. Induction and maintenance treatment of proliferative lupus nephritis: a meta-analysis of randomized controlled trials. Henderson LK; Masson P; Craig JC; Roberts MA; Flanc RS; Strippoli GF; Webster AC Am J Kidney Dis; 2013 Jan; 61(1):74-87. PubMed ID: 23182601 [TBL] [Abstract][Full Text] [Related]
14. Current management of lupus nephritis. Houssiau FA; Lauwerys BR Best Pract Res Clin Rheumatol; 2013 Jun; 27(3):319-28. PubMed ID: 24238689 [TBL] [Abstract][Full Text] [Related]
16. Treatment options for proliferative lupus nephritis: an update of clinical trial evidence. Navaneethan SD; Viswanathan G; Strippoli GF Drugs; 2008; 68(15):2095-104. PubMed ID: 18840001 [TBL] [Abstract][Full Text] [Related]
17. Defining the role of mycophenolate mofetil in the treatment of proliferative lupus nephritis. Lenz O; Fornoni A; Contreras G Drugs; 2005; 65(17):2429-36. PubMed ID: 16296869 [TBL] [Abstract][Full Text] [Related]
18. Towards new avenues in the management of lupus glomerulonephritis. Mok CC Nat Rev Rheumatol; 2016 Apr; 12(4):221-34. PubMed ID: 26729459 [TBL] [Abstract][Full Text] [Related]
20. Lupus nephritis: maintenance therapy for lupus nephritis--do we now have a plan? Lenz O; Waheed AA; Baig A; Pop A; Contreras G Clin J Am Soc Nephrol; 2013 Jan; 8(1):162-71. PubMed ID: 22917704 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]